ENVERIC

Welcome to the Brand page for “ENVERIC”, which is offered here for Pharmaceutical products and preparations for the treatment of medical conditions and disorders; pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment; anti-cancer preparations; pharmaceutical products for the treatment of cancer;pharmaceutical research services; medical research services; medical research laboratory services; research and development of new products for others; research and development services, for the development of a portfolio of psychoactive compounds and derivatives targeted for the treatment of medical conditions and disorders; research and development services, for the development of a portfolio of compounds and derivatives targeted for the treatment of cancer and the side effects of cancer; providing online non-downloadable computer software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical data and treatment data, in the field of medical research; scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical and medical research and development; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “ENVERIC” is believed to be currently owned by “Enveric Biosciences, Inc.”